Digital 11th Injectables Summit 2021

Memo

We are delighted to be meeting online again at the 11th Annual Injectables Summit and are dedicated to serve this community to streamline device development, explore new platforms and mitigate risks. Join global senior device leaders to share their latest innovations from pre-filled syringes to autoinjectors, novel formulations and technologies to offer better patient experience. We are aspired to help the community improve engineering excellence, with the 2021 summit focusing on: Fortifying User Centric Design Thinking in Your Injectable DeviceExtending Your Product Lifecycle ManagementUpdates of Evolving Global Regulatory LandscapesSmart DevicesHigh-Viscosity and High-Volume Injection Device Design and EngineeringSustainability and Reusability of Injectable DevicesDevice Engineering and Control Strategies URLs:Tickets: https://go.evvnt.com/824823-2?pid=5569Brochure: https://go.evvnt.com/824823-3?pid=5569 Prices:Conference Only - Pharma and Biotech: USD 1899.0,Conference Only - Solution Provider: USD 2349.0,Conference Only - Academic: USD 1649.0 Speakers: Daniel Latham, Head of Connected Health Product Development, Novartis, Khaudeja Bano, Executive Medical Director and Head of Combination Product Device Safety, Amgen, Nick Song, Director, Commercial Device Engineering, Takeda, Martin Ebro, Team Lead - Engineering Analysis, Device Research and Development, Novo Nordisk, Steve Chamberlain, Director Device Engineering, GSK, Markus Wierzoch, Head of Industrial Design, Eli Lilly and Co, Sindhuja Kuchibhatla, Device Development Engineer, New Technologies Management, Regeneron Pharmaceuticals, Emily Dubuc, Senior Engineer - Device Development, Regeneron Pharmaceuticals, Joyce Zhao, Associate Director, Combination Product, Takeda, Ed Israelski, Human Factors Consultant | CoCovener IEC/ISO Standards Groups for Usability Engineering Standards | Retired Director - Human Factors, AbbVie, Tieming Ruan, Senior Director of Device Development, Alexion Pharmaceuticals, James Leamon, Director, Biologics Device Development, Jazz Pharmaceuticals, Michael Roe, Senior Director, Development and Industrialization, Kaleo, Cindy Tritton, Senior Engineer II, Device Design and Development, Biogen, Casey Dean, Device Development Manager, Tolmar, Jiaying Shen, Distinguished Scientist, Merck and Co, Jamie Tsung, Associate Director, Alnylam Pharmaceuticals, Anthony Coston, Director of Program Management, Biogen, Alasdair Young, Director - Device Engineering, Coherus Biosciences, Emily Ho, Associate Director, Merck and Co, Jesper Bogelung, Program Manager of Device Design for Circularity, Novo Nordisk, Tim Quigg, Development Director, Crux Product Design Ltd, Senior Representative, Emergo by UL, Senior Representative, Datwyler Date and Time: On Wednesday October 20, 2021 at 8:30 am (ends Thursday October 21, 2021 at 6:30 pm)